IGF2 and breast carcinoma: Some early studies focused on allele-specific expression of the gene, with McCann and colleagues having observed biallelic expression of IGF2 in three of five informative breast carcinomas [30], while Yballe, et al. identified loss of IGF2 imprinting in 2 of 17 breast tissues [31].